Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
2009 to 2018 Saw Increase in Incidence of NAFLD in Children
12.3 percent of obese and overweight children with alanine aminotransferase >30 U/L received further workup for NAFLD
Group-Based Lifestyle Intervention Cuts Progression to T2DM
High-risk individuals making modest changes in weight, physical activity had lower odds of progressing to type 2 diabetes
AAP Urges Inclusion of Children in SARS-CoV-2 Vaccine Trials
AAP joins six other medical groups in letter requesting transparency and communication to improve confidence in a vaccine
Ebola Outbreak in Democratic Republic of the Congo Declared Over
Wednesday marks 42 days, or two incubation periods, since the last survivor tested negative for the virus
Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19
Findings seen among adult outpatients with SARS-CoV-2 with oxygen saturation of 92 percent or greater
Vitamin D Supplementation Tied to Reduction in Advanced Cancer
On stratification by BMI, significant reduction found in incident metastatic or fatal cancer in normal weight, not overweight/obese
Pandemic Affecting Young People’s Mental Health
Self-reported symptoms of depression, thoughts of suicide much higher than historical norms
FDA Approves First Rapid COVID-19 Test for Home Use
Simple nasal swab test requires prescription; people younger than 14 cannot perform the test on themselves
Triplet Therapy Slows Refractory Multiple Myeloma
Progression-free survival longer with once-weekly selinexor-containing regimen versus standard bortezomib and dexamethasone
